Promising pregnancy drug study pulled before it began
NCT ID NCT04275778
First seen Apr 17, 2026 · Last updated Apr 28, 2026 · Updated 2 times
Summary
This study aimed to see if adding hydroxychloroquine to standard treatment (aspirin and blood thinners) could help more women with antiphospholipid syndrome have a healthy full-term pregnancy. The trial was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTICOAGULANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Saint Antoine
Paris, 75012, France
Conditions
Explore the condition pages connected to this study.